
Weight loss drugs - fad or lifeline?
A YouGov study found Britons were split over whether weight loss drugs offer more health benefits than risks. Concerns include side effects and their longer-term impact.
Liverpool•localTV•local news•weight loss drugs•Mounjaro•Ozempic•YouGov•GLP-1 medicines•obesity treatment•health risks•health benefits•NHS•type 2 diabetes
Comments
Powered by RoundtableBuilt on infrastructure designed for real-time media. Learn more at RTB.io.© Roundtable 2026. By using this site you agree to the Terms of Use and Privacy Policy

